Literature DB >> 27795343

Combined Testing for Chlamydia, Gonorrhea, and Trichomonas by Use of the BD Max CT/GC/TV Assay with Genitourinary Specimen Types.

Barbara Van Der Pol1, James A Williams2, DeAnna Fuller3, Stephanie N Taylor4, Edward W Hook5.   

Abstract

The BD Max CT/GC/TV (MAX) assay is a true multiplex assay for simultaneous detection of chlamydia (CT), gonorrhea (GC), and trichomonas (TV). We evaluated assay performance for women using endocervical and vaginal swabs as well as urine specimens. A total of 1,143 women were tested for CT, GC, and TV and, subsequently, another 847 (1,990 total women) for CT and GC only, with positivity rates for CT, GC, and TV of 7.1%, 2.3%, and 13.5%, respectively. In men, the performance for CT and GC was determined using only urine specimens. TV performance was not assessed in male urine samples. Among men, 181/830 (21.8%) and 108/840 (12.9%) chlamydia and gonorrhea infections, respectively, were identified. Comparator assays included BD ProbeTec Chlamydia trachomatis Qx (CTQ)/Neisseria gonorrhoeae Qx (GCQ), Hologic Aptima Combo 2 (AC2) and Aptima TV (ATV), trichomonas microscopy, and culture. MAX CT sensitivity was 99.3% (95% confidence interval [CI], 96.1% to 99.9%), 95.7% (90.8% to 98.0%), 91.5% (85.8% to 95.1%), and 96.1% (92.2% to 98.1%) for vaginal swabs, endocervical swabs, female urine samples, and male urine samples, respectively. MAX GC sensitivity was 95.5% (84.9% to 98.7%), 95.5% (84.9% to 98.7%), 95.7% (85.5% to 99.8%), and 99.1% (94.9% to 99.8%) in the same order. MAX TV sensitivity was 96.1% (91.7% to 98.2%) for vaginal swabs, 93.4% (88.3% to 96.4%) for endocervical swabs, and 92.9% (87.8% to 96.0%) for female urine samples. Specificity for all organisms across all sample types was ≥98.6%. Performance estimates for the MAX assays were consistent with estimates calculated for the comparator assays (all P values were >0.1). The availability of a CT/GC/TV multiplexed assay on a benchtop instrument with a broad menu has the potential to facilitate local sexually transmitted infection (STI) testing at smaller laboratories and may encourage expanded screening for these highly prevalent infections.
Copyright © 2016 American Society for Microbiology.

Entities:  

Keywords:  Chlamydia trachomatis; Neisseria gonorrhoeae; Trichomonas vaginalis; molecular diagnostics; sexually transmitted infections

Mesh:

Year:  2016        PMID: 27795343      PMCID: PMC5228226          DOI: 10.1128/JCM.01766-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Microscopy outperformed in a comparison of five methods for detecting Trichomonas vaginalis in symptomatic women.

Authors:  B Nathan; J Appiah; P Saunders; D Heron; T Nichols; R Brum; S Alexander; P Baraitser; C Ison
Journal:  Int J STD AIDS       Date:  2014-05-22       Impact factor: 1.359

2.  A comparison of the sensitivity of the InPouch TV, Diamond's and Trichosel media for detection of Trichomonas vaginalis.

Authors:  K A Borchardt; M Z Zhang; H Shing; K Flink
Journal:  Genitourin Med       Date:  1997-08

3.  Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay.

Authors:  C C Ginocchio; K Chapin; J S Smith; J Aslanzadeh; J Snook; C S Hill; C A Gaydos
Journal:  J Clin Microbiol       Date:  2012-05-23       Impact factor: 5.948

4.  Clinical evaluation of the BD ProbeTec™ Neisseria gonorrhoeae Qx amplified DNA assay on the BD Viper™ system with XTR™ technology.

Authors:  Barbara Van Der Pol; Stephanie N Taylor; William Lebar; Thomas Davis; Deanna Fuller; Leandro Mena; Paul Fine; Charlotte A Gaydos; David H Martin; Edward W Hook
Journal:  Sex Transm Dis       Date:  2012-02       Impact factor: 2.830

5.  Chlamydia trachomatis antigens recognized in women with tubal factor infertility, normal fertility, and acute infection.

Authors:  Nicole M Budrys; Siqi Gong; Allison K Rodgers; Jie Wang; Christopher Louden; Rochelle Shain; Robert S Schenken; Guangming Zhong
Journal:  Obstet Gynecol       Date:  2012-05       Impact factor: 7.661

6.  Performance of the cobas CT/NG test compared to the Aptima AC2 and Viper CTQ/GCQ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  Barbara Van Der Pol; Oliver Liesenfeld; James A Williams; Stephanie N Taylor; Rebecca A Lillis; Barbara A Body; Mindy Nye; Carol Eisenhut; Edward W Hook
Journal:  J Clin Microbiol       Date:  2012-04-18       Impact factor: 5.948

7.  Chlamydia trachomatis infection and pregnancy outcome.

Authors:  R L Sweet; D V Landers; C Walker; J Schachter
Journal:  Am J Obstet Gynecol       Date:  1987-04       Impact factor: 8.661

8.  The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.

Authors:  Madeline Sutton; Maya Sternberg; Emilia H Koumans; Geraldine McQuillan; Stuart Berman; Lauri Markowitz
Journal:  Clin Infect Dis       Date:  2007-10-15       Impact factor: 9.079

9.  Performance of the Cepheid CT/NG Xpert Rapid PCR Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  Charlotte A Gaydos; Barbara Van Der Pol; Mary Jett-Goheen; Mathilda Barnes; Nicole Quinn; Carey Clark; Grace E Daniel; Paula B Dixon; Edward W Hook
Journal:  J Clin Microbiol       Date:  2013-03-06       Impact factor: 5.948

Review 10.  Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis.

Authors:  Bronwyn J Silver; Rebecca J Guy; John M Kaldor; Muhammad S Jamil; Alice R Rumbold
Journal:  Sex Transm Dis       Date:  2014-06       Impact factor: 2.830

View more
  13 in total

1.  Comparison between DiaPlexQ™ STI6 and GeneFinder™ STD I/STD II multiplex Real-time PCR Kits in the detection of six sexually transmitted disease pathogens.

Authors:  Hee Jae Huh; Chang-Seok Ki; Sun Ae Yun; Jungsoo Lee; Gwi Young Oh; Nam-Sihk Lee; Young Ho Yoon; Nam Yong Lee
Journal:  J Clin Lab Anal       Date:  2018-11-02       Impact factor: 2.352

Review 2.  Management of Resistant Trichomoniasis.

Authors:  Cynthia Alessio; Paul Nyirjesy
Journal:  Curr Infect Dis Rep       Date:  2019-08-06       Impact factor: 3.725

3.  Performance of 4 Molecular Assays for Detection of Chlamydia and Gonorrhea in a Sample of Human Immunodeficiency Virus-Positive Men Who Have Sex With Men.

Authors:  Alison Footman; Jodie Dionne-Odom; Kristal J Aaron; James L Raper; Barbara Van Der Pol
Journal:  Sex Transm Dis       Date:  2020-03       Impact factor: 2.830

Review 4.  Protection and Risk: Male and Female Genital Microbiota and Sexually Transmitted Infections.

Authors:  Susan Tuddenham; Jacques Ravel; Jeanne M Marrazzo
Journal:  J Infect Dis       Date:  2021-06-16       Impact factor: 5.226

5.  Evaluation of the performance of nucleic acid amplification tests (NAATs) in detection of chlamydia and gonorrhoea infection in vaginal specimens relative to patient infection status: a systematic review.

Authors:  Minttu M Rönn; Louise Mc Grath-Lone; Bethan Davies; Janet D Wilson; Helen Ward
Journal:  BMJ Open       Date:  2019-01-17       Impact factor: 2.692

6.  Simultaneous detection of eleven sexually transmitted agents using multiplexed PCR coupled with MALDI-TOF analysis.

Authors:  Leshan Xiu; Chi Zhang; Yamei Li; Feng Wang; Junping Peng
Journal:  Infect Drug Resist       Date:  2019-08-28       Impact factor: 4.003

Review 7.  The Laboratory Diagnosis of Neisseria gonorrhoeae: Current Testing and Future Demands.

Authors:  Thomas Meyer; Susanne Buder
Journal:  Pathogens       Date:  2020-01-31

Review 8.  Current and Future Perspectives on Isothermal Nucleic Acid Amplification Technologies for Diagnosing Infections.

Authors:  Godwin Attah Obande; Kirnpal Kaur Banga Singh
Journal:  Infect Drug Resist       Date:  2020-02-12       Impact factor: 4.003

9.  Performance of point-of-care tests for the detection of chlamydia trachomatis infections: A systematic review and meta-analysis.

Authors:  Ying Zhou; Ting-Ting Jiang; Jing Li; Yue-Ping Yin; Xiang-Sheng Chen
Journal:  EClinicalMedicine       Date:  2021-06-18

Review 10.  A profile of the binx health io® molecular point-of-care test for chlamydia and gonorrhea in women and men.

Authors:  Barbara Van Der Pol; Charlotte A Gaydos
Journal:  Expert Rev Mol Diagn       Date:  2021-07-12       Impact factor: 5.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.